Acquisition Overview

On October 16, 2026, Cotecna Group, a Swiss‑based provider of Testing, Inspection and Certification (TIC) services, announced the acquisition of Energon Labs, a cGMP‑compliant, USFDA‑inspected analytical testing laboratory located in Hyderabad, India. Energon Labs holds ISO 9001:2015 and ISO 17025:2017 certifications and serves customers across India, the United States, Asia‑Pacific and the Middle East.

Strategic Rationale and Scope

The acquisition strengthens Cotecna’s global Life Sciences platform and expands its pharmaceutical testing capabilities across the pharmaceutical, biopharmaceutical, medical device and packaging sectors. By integrating Energon’s laboratory, Cotecna gains access to highly specialized scientific talent, advanced laboratory infrastructure, and a well‑established pharmaceutical ecosystem in Hyderabad – one of the world’s leading pharma and biotechnology hubs. India, identified as one of the fastest‑growing pharmaceutical markets and a critical manufacturing hub for global healthcare supply chains, will benefit from enhanced responsiveness, scalability and operational efficiency.

Service Portfolio Expansion

Energon Labs offers a comprehensive suite of analytical and quality‑assurance services, including:

  • Analytical method development and validation
  • Stability studies and impurity profiling
  • Extractables and leachables testing
  • Glass delamination studies
  • Peptide and oligonucleotide characterisation
  • Raw material and finished product testing
  • In‑vitro binding studies
  • Packaging compatibility studies
  • Regulatory support services

These capabilities complement Cotecna’s existing pharmaceutical testing network, which includes Cotecna Life Sciences, Shiva Analyticals and Neotron Pharma.

Executive Comments

Sébastien Dannaud, Chief Executive Officer of Cotecna Group, stated that the acquisition is an important step toward Cotecna’s ambition to become one of the largest providers of Life Sciences testing services in India and reinforces its position in a key pharmaceutical market. Amit Chopra, CEO South Asia and Middle East of Cotecna Group, highlighted that Energon’s technical expertise, experienced team and established customer relationships will enhance Cotecna’s ability to serve pharmaceutical, biopharmaceutical and medical device companies across India and globally. Manikanth Reddy, Founder of Energon Labs, expressed enthusiasm about joining the Cotecna Group, noting that the partnership will enable further capability expansion and greater value delivery to customers while maintaining the highest standards of analytical excellence.

Company Backgrounds

Energon Labs is a cGMP‑compliant, USFDA‑inspected laboratory with ISO 9001:2015 and ISO 17025:2017 certifications, providing analytical testing, quality assurance and regulatory support services to the pharmaceutical, biopharmaceutical, medical device and packaging industries. Cotecna, founded in Switzerland in 1974, operates in more than 55 countries and offers TIC services across agriculture and food, pharmaceuticals, minerals and metals, consumer products, certification and ESG services.